Navigation Links
Warner Chilcott Agrees to Terminate Existing Co-Promotion Agreement and Acquire U.S. Rights to Enablex® Overactive Bladder Treatment for $400 Million in Cash
Date:9/24/2010

ic staff; adverse outcomes in our outstanding litigation or an increase in the number of litigation matters to which we are subject; government regulation, including domestic and foreign health care reform, affecting the development, manufacture, marketing and sale of pharmaceutical products, including our ability and the ability of companies with whom we do business to obtain necessary regulatory approvals; our ability to manage the growth of our business by successfully identifying, developing, acquiring or licensing new products at favorable prices and marketing such new products; our ability to obtain regulatory approval and customer acceptance of new products, and continued customer acceptance of our existing products; changes in tax laws or interpretations that could increase our consolidated tax liabilities; our ability to realize the anticipated opportunities from our acquisition of the global branded pharmaceuticals business from The Procter and Gamble Company; the other risks identified in our periodic filings including our Annual Report on Form 10-K for the year ended December 31, 2009, and from time-to-time in our other investor communications.

We caution you that the foregoing list of important factors is not exclusive.  In addition, in light of these risks and uncertainties, the matters referred to in our forward-looking statements may not occur.  We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as may be required by law.


'/>"/>
SOURCE Warner Chilcott plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Warner Chilcott Announces $500 Million Senior Notes Offering in Connection With Agreement to Acquire U.S. Rights to Enablex®
2. Warner Chilcott to Present at UBS Global Life Sciences Conference
3. Warner Chilcott Announces Receipt of FDA Response to Citizen Petition
4. Warner Chilcott Completes Amendment to Existing Senior Secured Credit Facilities and Closes Senior Notes Offering; Company Declares Special Cash Dividend of $8.50 Per Share and Updates Full-Year 2010 Financial Guidance
5. Warner Chilcott Announces Earnings Release Date and Conference Call for Second Quarter 2010 Financial Results
6. Warner Chilcott Announces 3-Month Extension of PDUFA Date on Next Generation Actonel Product
7. Warner Chilcott Announces Receipt of Paragraph IV Certification Notice
8. Warner Chilcott to Present at the Wells Fargo Securities Healthcare Conference
9. Warner Chilcott to Present at the Bank of America Merrill Lynch Healthcare Conference
10. Warner Chilcott Announces Earnings Release Date and Conference Call For First Quarter 2010 Financial Results
11. Warner Chilcott Announces 2010 Financial Guidance Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... , Sept. 22, 2014  Neuralstem, Inc. (NYSE MKT: CUR) ... investigator at Emory University, presented long-term follow up data ... stem cells in the treatment of amyotrophic lateral sclerosis ... which occurred at the Annual Symposium on ALS of ... , on Friday, and was not open to the ...
(Date:9/22/2014)... Pa. , Sept. 22, 2014  Olympus, ... innovative solutions for medical and surgical procedures, among ... a deal with Munich -based ... Kick ® Navigation. This agreement applies to ... for cross-disciplinary U.S. sales and all distribution outside ...
(Date:9/22/2014)... MEETING, Pa. , Sept. 22, 2014 /PRNewswire/ ... announced today it has initiated a phase I ... trial will evaluate the safety, tolerability, and immunogenicity ... 6 (HPV-6), which causes most aerodigestive cancers. ... nose, throat, vocal cords, and parts of the ...
Breaking Medicine Technology:Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 2Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 3Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 4Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 2Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 3Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 4Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 2Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 3Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 4
... Mylan Inc. (Nasdaq: MYL ) today announced ... from the U.S. Food and Drug Administration (FDA) for its ... 8.5 mg, 17 mg, 25.5 mg and 34 mg. Mylan ... ANDA containing a Paragraph IV certification for Nisoldipine ER Tablets ...
... Inc. (Amex: AEN ), a developer of innovative ... it has executed an agreement for the sale of approximately ... share to two new institutional investors in a registered direct ... also receive warrants to purchase approximately 1.42 million shares of ...
Cached Medicine Technology:Adeona to Raise $4 Million in Registered Direct Offering 2Adeona to Raise $4 Million in Registered Direct Offering 3
(Date:9/23/2014)... 23, 2014 WetKeys Washable Keyboards announces ... in their industrial keyboards line. Labeled ... to last longer in heavy-duty industrial computing for the ... where grease and oil can destroy usability or cause ... constant threat to the longevity of computer equipment and ...
(Date:9/23/2014)... September 23, 2014 Névo takes a ... precision timepiece and adding advanced activity tracking and phone ... monitors steps, distance, calories burned, and more. , ... to adopt healthy habits in their busy lives to ... small changes that produce healthy results, but until now, ...
(Date:9/23/2014)... (PRWEB) September 23, 2014 Many people have ... Everyone has seen nightclub or television acts in which a ... members and then uses the power of suggestion to have ... have also heard about hypnosis as an aid in managing ... only a fraction of the ways hypnotism can be used. ...
(Date:9/23/2014)... Texas (PRWEB) September 23, 2014 Medicine in ... its central Austin location at 711 W. 38th, Suite G4. ... at their north Austin location, increased demand for MIM’s superior ... “My team and I are extremely excited about bringing our ... Martha Pyron, owner of Medicine in Motion. “We’ll continue to ...
(Date:9/23/2014)... Recently, BuyTopDress.com, a popular supplier of wedding dresses and special ... fashionable marine ball dresses . Along with this, the ... brand new items; all of them are now provided with ... now, BuyTopDress.com has won more than 2000 happy customers in ... its products and after-sale services. The company is offering thousands ...
Breaking Medicine News(10 mins):Health News:WetKeys Announces New Oil Resistant Keyboard for Industrial Computing, Food Processing Plants, Automotive Factories and Machine Shops 2Health News:WetKeys Announces New Oil Resistant Keyboard for Industrial Computing, Food Processing Plants, Automotive Factories and Machine Shops 3Health News:WetKeys Announces New Oil Resistant Keyboard for Industrial Computing, Food Processing Plants, Automotive Factories and Machine Shops 4Health News:WetKeys Announces New Oil Resistant Keyboard for Industrial Computing, Food Processing Plants, Automotive Factories and Machine Shops 5Health News:Nevo changes the face of fitness wearables with an analogue watch combining activity tracking, phone notifications, and LED goal progress indicators for active lifestyles 2Health News:Nevo changes the face of fitness wearables with an analogue watch combining activity tracking, phone notifications, and LED goal progress indicators for active lifestyles 3Health News:Hypnosis: What You Don't Know, Dr. Richard Dauber with Morris Psychological Group Dispels Myths and Offers Tips about a Valuable Therapeutic Approach 2Health News:Hypnosis: What You Don't Know, Dr. Richard Dauber with Morris Psychological Group Dispels Myths and Offers Tips about a Valuable Therapeutic Approach 3Health News:Hypnosis: What You Don't Know, Dr. Richard Dauber with Morris Psychological Group Dispels Myths and Offers Tips about a Valuable Therapeutic Approach 4Health News:Austin Sports Medicine Practice to Host Grand Opening Event for Second Location 2Health News:Fashionable Marine Ball Dresses Added To BuyTopDress.com’s Collection 2
... detected with self-illuminating polymers. The originators, at Linkping University ... can also render the prions harmless, and potentially cure ... at the University Hospital in Zrich tested the luminescent ... brains of mice that had been infected with prions. ...
... controlled by lightning-quick electrical impulses in the brain, the ... in the membranes of the cells can cause things ... Linkping University has now published new discoveries that can ... key molecules behind the electrical impulses are voltage-activated ion ...
... cellular protein called HDAC6, newly characterized as a gatekeeper ... novel target for treating and preventing stress-linked disorders, such ... research from the Perelman School of Medicine at the ... secreted by the body during stress. A small amount ...
... (HealthDay News) -- The shingles vaccine is generally safe and ... Shingles, which affects more than 1 million people each year ... by the dormant chickenpox virus, which can reactivate and replicate, ... risk because immunity against the virus that causes shingles declines ...
... Canada demonstrated the unequivocal effectiveness of brain surgeries for ... not been widely adoptedin fact, it is dramatically underutilized ... California, San Francisco (UCSF). The study, published this ... the number of Americans having the surgery has not ...
... , MONDAY, April 23 (HealthDay News) -- It goes without ... dangerous, but they can also be very expensive, an expert ... uncommon for a person bitten by a venomous snake, said ... A&M University in College Station. The total cost includes ...
Cached Medicine News:Health News:Prions in the brain eliminated by homing molecules 2Health News:Molecule movements that make us think 2Health News:Gatekeeper of brain steroid signals boosts emotional resilience to stress 2Health News:Gatekeeper of brain steroid signals boosts emotional resilience to stress 3Health News:Shingles Vaccine Safe, Underutilized, Study Says 2Health News:Brain surgery for epilepsy underutilized 2Health News:Brain surgery for epilepsy underutilized 3Health News:Cost of Snakebite Therapy May Squeeze Victims' Wallets 2
... was the first device ... after diagnostic and interventional ... It is a collagen-based ... for immediate sheath removal ...
... Surgical Hemostats First Stop absorbable collagen ... that offers superior handling and removal characteristics. ... and tailored to fit the wound. FirstStop ... can easily be peeled away after hemostasis ...
InterVascular HemaCarotid Patch product line offers the vascular surgeon a complete range of knitted, collagen coated patches in a wide range of sizes for carotid endarterectomy and angioplasty witho...
The VasoSeal Low Profile device is designed for smaller sheath angiography procedures. VasoSeal Low Profile. Seal your arterial punctures with confidence....
Medicine Products: